Pure Global

Effects of Aerobic Versus Resistance Training in Post Percutaneous Coronary Intervention Obese Patients - Trial NCT06308276

Access comprehensive clinical trial information for NCT06308276 through Pure Global AI's free database. This phase not specified trial is sponsored by Riphah International University and is currently Recruiting. The study focuses on Cardiovascular Diseases. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06308276
Recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT06308276
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Effects of Aerobic Versus Resistance Training in Post Percutaneous Coronary Intervention Obese Patients
Effects of Aerobic Versus Resistance Training on Blood Pressure, Cardiorespiratory Fitness and Quality of Life in Post Percutaneous Coronary Intervention Obese Patients

Study Focus

Cardiovascular Diseases

Aerobic Training

Interventional

other

Sponsor & Location

Riphah International University

Sialkot, Pakistan

Timeline & Enrollment

N/A

Mar 01, 2024

Jun 15, 2024

50 participants

Primary Outcome

Blood Pressure,Six Minute Walk Test,SF 36 Questionnaire

Summary

The randomized clinical trial (RCT) endeavors to enroll 50 participants, divided equally into
 aerobic exercise and resistance exercise groups. The study employs rigorous tools such as
 blood pressure measurement, SF-36 questionnaire, and the Six-Minute Walk Test (6MWT) to
 assess VO2max.

ICD-10 Classifications

Cardiovascular disease, unspecified
Hypertensive heart disease
Other ill-defined heart diseases
Heart disease, unspecified
Observation for other suspected cardiovascular diseases

Data Source

ClinicalTrials.gov

NCT06308276

Non-Device Trial